The Ellison Medical Foundation, 4710 Bethesda Ave., Suite 204, Bethesda, MD 20814, USA.
Exp Gerontol. 2010 Jan;45(1):2-4. doi: 10.1016/j.exger.2009.07.008. Epub 2009 Aug 3.
The concept of biomarkers of aging and age-related disease dates to the early 1980s as scientists engaged in aging research worked to clearly define aging and separate processes from disease with better prediction of both as an objective. The concept of basic aging processes, separate from disease, was then, and still is, not universally accepted. While the search for biomarkers of aging has a relatively long and difficult history, the search for biomarkers of disease is conceptually more straightforward. The biomarkers discussed in this issue are generally easier to understand, can be related to relevant functions, and often are the product of concentrated research interest. Further, these biomarkers could lead to earlier and more successful treatments and thus are often of very immediate interest. After a long period of concentration on lifespan extension and longevity by basic biologists, there is now a growing interest in health-span research. The reviews in this issue provide a strong rationale for increased interchange between basic biologists and their clinical colleagues.
衰老和与年龄相关疾病的生物标志物的概念可以追溯到 20 世纪 80 年代早期,当时从事衰老研究的科学家们致力于明确衰老的定义,并通过更好地预测衰老和疾病过程将其与疾病区分开来。从那时起,甚至到现在,基本衰老过程与疾病分开的概念仍然没有被普遍接受。虽然寻找衰老的生物标志物具有相对较长和困难的历史,但寻找疾病的生物标志物在概念上更为直接。本专题中讨论的生物标志物通常更容易理解,可以与相关功能相关,并且通常是集中研究兴趣的产物。此外,这些生物标志物可以导致更早和更成功的治疗,因此通常具有非常直接的意义。在基础生物学家长期专注于延长寿命和长寿之后,现在对健康寿命研究的兴趣日益增加。本专题中的综述为基础生物学家与其临床同事之间增加交流提供了强有力的理由。